ImgAssist AI
AI-powered real-time imaging system for intraoperative margin assessment during breast cancer surgery
Company profile
Company profile
Perimeter Medical Imaging AI is a medical technology company focused on transforming cancer surgery through advanced imaging and artificial intelligence. The company has developed ImgAssist AI, an innovative platform that combines ultra-high-resolution optical coherence tomography (OCT) imaging with AI-powered analysis to provide surgeons with real-time tissue assessment during breast-conserving surgery. The technology enables intraoperative margin assessment, helping surgeons visualize microscopic tissue structures at the point of care without waiting for traditional pathology results. By providing immediate feedback on whether cancer cells remain at the surgical margins, Perimeter's solution aims to reduce the need for additional surgeries, improve patient outcomes, and lower healthcare costs. The company serves hospitals, surgical centers, and healthcare systems performing breast cancer procedures. Perimeter Medical Imaging AI is committed to advancing precision surgery through the integration of cutting-edge imaging technology and machine learning algorithms that support clinical decision-making in the operating room.
Company description Perimeter Medical Imaging AI official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded deployment with recorded integration context.
Company milestones
FDA clearance for ImgAssist AI platform
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered real-time imaging system for intraoperative margin assessment during breast cancer surgery
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Life (Basel, Switzerland) · Dec 14, 2023
Wide-field optical coherence tomography for microstructural analysis of key tissue types: a proof-of-concept evaluation.Pathology oncology research : POR · Jan 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
P250008 · Pma · Mar 3, 2026
OTIS 2.1 Optical Coherence Tomography System, THiA Optical Coherence Tomography SystemK203578 · 510k · Feb 25, 2021
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
breast-conserving surgery
intraoperative decision support
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Perimeter Medical Imaging AI's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.